RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)Poulikos I. Poulikakos, David B. Solit, Hubing Shi et al.|Nature|2011Cited by 1.4k
<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF InhibitorsFei Su, Jeffrey A. Sosman, Amaya Virós et al.|New England Journal of Medicine|2012Cited by 1k
Therapy-induced tumour secretomes promote resistance and tumour progressionAnna C. Obenauf, Joan Massagué, Andrew L. Ji et al.|Nature|2015Cited by 502